AKRO - Akero Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKRO (1744659)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

34 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2021-01-08
AKROYoung JonathanCOOS - Sale+OE$28.12-10,000239,285-4%-$281,200
2021-01-04
AKROYoung JonathanCOOS - Sale$25.29-3,060241,785-1%-$77,399
2020-10-09
AKROBitterman KevinDirS - Sale$28.93-13,0002,523,075-1%-$376,090
2020-07-10
AKROApple Tree Partners Iv, L.P.10%P - Purchase$36.00+415,0005,830,203+8%+$14,940,000
2020-07-10
AKROHarrison Seth LoringDir, 10%P - Purchase$36.00+415,0005,830,203+8%+$14,940,000
AM
2020-01-07
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.99-53,0572,846,941-2%-$1,060,845
AM
2020-01-02
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.70-72,4442,899,998-2%-$1,427,272
M
2020-07-01
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$34.40-116,4673,033,552-4%-$4,006,537
M
2020-03-04
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$23.76-45,9503,150,019-1%-$1,091,608
M
2020-02-28
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$22.63-21,7983,195,969-1%-$493,310
M
2020-02-25
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$22.80-5,9043,227,7670%-$134,635
M
2020-02-10
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$27.07-10,0263,233,6710%-$271,399
2020-02-06
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$27.03-6,1023,233,6970%-$164,955
M
2020-02-04
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$25.77-82,3393,239,799-2%-$2,121,726
M
2020-01-16
AKROVersant Venture Capital Vi, L.P.10%S - Sale$20.87-59,5323,092,698-2%-$1,242,403
M
2020-01-10
AKROVersant Venture Capital Vi, L.P.10%S - Sale$20.04-50,8373,152,230-2%-$1,018,571
2020-01-13
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$20.23-494,0003,322,138-13%-$9,993,620
2020-01-08
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.86-15,6773,816,1380%-$311,355
M
2020-01-07
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.99-53,0573,203,067-2%-$1,060,845
M
2020-01-06
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.86-73,2213,831,815-2%-$1,454,530
M
2020-01-02
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.70-72,4443,256,124-2%-$1,427,272
M
2020-01-02
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.71-35,4983,905,036-1%-$699,721
2019-12-31
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$23.96-14,3243,940,5340%-$343,259
AM
2019-12-27
AKROVersant Venture Capital Vi, L.P.10%S - Sale$24.20-389,3823,656,585-10%-$9,421,175
M
2019-12-27
AKROVersant Venture Capital Vi, L.P.10%S - Sale$24.20-389,3823,656,585-10%-$9,421,175
M
2019-12-20
AKROVersant Venture Capital Vi, L.P.10%S - Sale$21.34-49,2204,045,967-1%-$1,050,416
M
2019-12-17
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.56-9,6714,095,1870%-$189,197
D
2019-06-24
AKROBitterman KevinDirP - Purchase$16.00+270,000505,099+115%+$4,320,000
D
2019-06-24
AKROAtlas Venture Fund Xi, L.P.10%P - Purchase$16.00+270,000505,099+115%+$4,320,000
D
2019-06-24
AKRORoyston AaronDirP - Purchase$16.00+250,0003,954,858+7%+$4,000,000
D
2019-06-24
AKROVersant Venture Capital Vi, L.P.10%P - Purchase$16.00+400,0004,104,858+11%+$6,400,000
D
2019-06-24
AKROHarrison Seth LoringDir, 10%P - Purchase$16.00+900,0005,415,203+20%+$14,400,000
D
2019-06-24
AKROApple Tree Partners Iv, L.P.10%P - Purchase$16.00+900,0005,415,203+20%+$14,400,000
D
2019-06-24
AKROVenbio Global Strategic Fund II L.P.10%P - Purchase$16.00+250,0003,954,858+7%+$4,000,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top